Cases

Towa Pharmaceutical Co., Ltd. - Acquisition of Spain’s Pensa Investments, S.L.

Leading Japanese law firm Nishimura & Asahi advised Towa Pharmaceutical Co., Ltd. [TSE: 4553], a Japanese generic drug company, on its acquisition of Pensa Investments, S.L., the generics division of Spanish pharmaceutical companies  Corporación Químico Farmacéutica Esteve, S.A. and Esteve Pharmaceuticals, S.A., in an all-cash deal for EUR 320 million.

The Nishimura & Asahi team advising Towa Pharmaceutical was led by partners Yoshinobu Fujimoto, Yoshiyuki Kizu and Dominik Kruse, supported by Mihoko Hori, Daisuke Hoshino, Junko Wakabayashi, Satoshi Aizawa and James Campbell.